Dignitana
Manufacturing · Sweden · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Traktorgränden Lund 3 27, Lund, Skane, 2...Phone Number
+46 46163090Website
www.dignitana.comRevenue
$9.9 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About Dignitana
Dignitana AB is a Swedish medical technology company that develops, produces, and markets the DigniCap Scalp Cooling System, designed to minimize hair loss during chemotherapy for cancer patients. The system has been FDA cleared and is effective for patients undergoing treatment for various solid tumors, including breast and prostate cancers. With a focus on improving patient well-being and quality of life, Dignitana aims to provide a clinically superior solution for hair preservation during chemotherapy. The company operates in multiple countries, including the United States and Italy, and is publicly traded on Nasdaq First North Growth Market.Explore more
Dignitana Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Dignitana your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if Dignitana has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Dignitana has new funding data
Dignitana, which may be a good buyer, showed buying intent in Masked Content Topic
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Check out if Dignitana is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Dignitana
Earning: See what the market has to say on Dignitana recently announced quarterly report
Product Launch: Get notified when Dignitana launches new products
Click to see if Dignitana had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Dignitana is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Dignitana is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Dignitana.
Dignitana financials insights
Gather financial insights about Dignitana, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Debt
$350K
Dignitana Tech Stack
A closer look at the technologies used by Dignitana
Most Recent Scoops
Mergers & Acquisitions (M&A)
Mergers & Acquisitions, Acquisitions, Mergers
Left Company
Executive Move
Executive Moves, Left Company
New Hire
Executive Move
Executive Moves, New Hire
New Hire
Executive Move
Executive Moves, New Hire
Left Company
Executive Move
Executive Moves, Left Company
Dignitana News & Media
Statement by the Board of Directors of Dignitana regarding the public offer from Paxman
The Board of Directors unanimously recommends the shareholders to accept the offer. ThisDignitana AB Publishes Q3 2024 Interim Report
More progress in reimbursement Financial highlights Q3 2024 · Net Sales amounted to 22.8 MSEK (22.2), an increase of 3 percent over the same quarter in 2023. · Operating Result amounted to -0.7 MSEK (-3.2). · Net Result after financial items amounted to -1.5 MSEK (-3.7). · EBITDA for the third quarter is positive at 2.1 MSEK (0.7). · Earnings per share were -0.02 SEK (-0.05). · Cash Balance amounted to 4.4 MSEK (7.0). ·Dignitana AB (publ) appoints Nomination Committee for Annual General Meeting 2025
The Dignitana Annual General Meeting 2025 will be held on 22 May 2025. The Nomination Committee for the Dignitana Annual General Meeting 2025 consists of: · Greg Dingizian, Chairman of the Board and Owner of Agartha AB on closely related company's mandate · Magnus Sjöqvist, Swedbank Robur Fonder AB on closely related company mandate · Bill Cronin, UBS Financial Services Inc. on closely related company mandate · Klas Arildsson, Chairman of the Board TheUniversity Hospital Schleswig-Holstein in Kiel, Germany selects DigniCap
Dignitana AB (http://www.dignitana.com/) announces that the highly ranked University Hospital Schleswig-Holstein (http://www.unifrauenklinik-kiel.de/) (UKSH) in Kiel, Germany will offer DigniCap for patients at the Clinic for Gynecology and Obstetrics. The clinic acquired two DigniCap Delta devices and the staff completed the training in October. UKSH chose DigniCap based on the advanced technology in the DigniCap Delta device which is designed to improve patient outcomes and ease of use. “UKSH
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Dignitana
Sign Up For FreeTo access detailed company insights
Dignitana AB is a Swedish medical technology company that develops, produces, and markets the DigniCap Scalp Cooling System, designed to minimize hair loss during chemotherapy for cancer patients. The system has been FDA cleared and is effective for patients undergoing treatment for various solid tumors, including breast and prostate cancers. With... Read More
